{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:25:30Z","timestamp":1769120730688,"version":"3.49.0"},"reference-count":54,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"abstract":"<jats:p>Background. Leukemoid reaction (LR) is defined as an absolute neutrophil count (ANC) of &amp;gt;30 \u00d7 103\/mm3. No previous study has systemically examined the clinical and prognostic significance of this phenomenon in extremely low birth weight (ELBW) infants.<\/jats:p><jats:p>Objective. The purpose of this study was to examine the effect of LR in morbidity, mortality, and long-term developmental outcome in ELBW infants.<\/jats:p><jats:p>Method. Infants with gestational age of \u226430 weeks and birth weight \u22641000 g were included in the study (n = 152). The medical records were reviewed for the clinical characteristics and long-term developmental outcome of these infants. Serial complete blood cell count and ANC were calculated on day 1 and weekly thereafter until discharge. LR was defined as an ANC of &amp;gt;30 \u00d7 103\/mm3.<\/jats:p><jats:p>Results. LR was detected in 17% of the study infants (26 of 152). ANC increased postnatally in LR (n = 26) and no-LR (n = 126) infants during hospitalization, peaked in the second week of life (43 \u00b1 3 vs 14 \u00b1 1 \u00d7 103\/mm3), and remained significantly higher in LR infants during the first 5 weeks of life. LR occurred more frequently during the first 2 weeks of life and lasted for 3 \u00b1 1 days. There was no significant difference between the LR and no-LR infants in gestational age, birth weight, delivery mode, gender, Apgar scores, or incidence of respiratory distress syndrome, patent ductus arteriosus, necrotizing enterocolitis, intraventricular hemorrhage, and retinopathy of prematurity. LR infants required a significantly longer duration of ventilatory support (36 \u00b1 4 vs 21 \u00b1 2 days), longer duration of oxygen requirement (58 \u00b1 6 vs 40 \u00b1 3 days), and had a higher incidence of bronchopulmonary dysplasia (BPD) (54% vs 25%) compared with no-LR infants. Furthermore, the length of hospitalization was significantly longer in LR infants (69 \u00b1 6 vs 54 \u00b1 3 days). There was no significant difference between the groups in developmental outcome at 2 years of age including receptive\/expressive language, fine\/gross motor skills, and hearing. Incidence of abnormal neurodevelopment outcome was also similar between LR and no-LR infants.<\/jats:p><jats:p>Conclusions. LR in ELBW infants is associated with a prolonged need for ventilatory and oxygen support, a higher incidence of BPD, and a tendency for lower mortality. The findings from our study suggest that LR is associated with conditions known to have an excess of proinflammatory cytokines. Additional prospective study is needed to understand the relationship between LR, proinflammatory cytokines, and development of BPD.<\/jats:p>","DOI":"10.1542\/peds.2004-1379","type":"journal-article","created":{"date-parts":[[2005,6,2]],"date-time":"2005-06-02T00:33:41Z","timestamp":1117672421000},"page":"e43-e51","source":"Crossref","is-referenced-by-count":31,"title":["Outcome of Extremely Low Birth Weight Infants With Leukemoid Reaction"],"prefix":"10.1542","volume":"116","author":[{"given":"Robert","family":"Hsiao","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, Michigan; and Division of Neonatology, Sparrow Regional Children's Center, Lansing, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said A.","family":"Omar","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, Michigan; and Division of Neonatology, Sparrow Regional Children's Center, Lansing, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,7,1]]},"reference":[{"key":"2021120905521116300_R1","doi-asserted-by":"crossref","unstructured":"Rijken M, Stoelhorst GM, Martens SE, et al. Mortality and neurologic, mental and psychomotor development at 2 years in infants born less than 27 weeks' gestation: the Leiden follow-up project on prematurity. Pediatrics.\u20082003;112:351\u2013358","DOI":"10.1542\/peds.112.2.351"},{"key":"2021120905521116300_R2","doi-asserted-by":"crossref","unstructured":"Emsley HC, Wardle SP, Sims DG, Chiswick ML, D'Souza SW. Increased survival and deteriorating developmental outcome in 23\u201325 week old gestation infants, 1990\u20134 compared with 1984\u20139. Arch Dis Child Fetal Neonatal Ed.\u20081998;78:F99\u2013F104","DOI":"10.1136\/fn.78.2.F99"},{"key":"2021120905521116300_R3","doi-asserted-by":"crossref","unstructured":"McElrath TF, Robinson JN, Ecker JL, Ringer SA, Norwitz ER. Neonatal outcome of infants born at 23 weeks' gestation. Obstet Gynecol.\u20082001;97:49\u201352","DOI":"10.1097\/00006250-200101000-00010"},{"key":"2021120905521116300_R4","doi-asserted-by":"crossref","unstructured":"Jacobs SE, O'Brien K, Inwood S, Kelly EN, Whyte HE. Outcome of infants 23\u201326 weeks' gestation pre and post surfactant. Acta Paediatr.\u20082000;89:959\u2013965","DOI":"10.1111\/j.1651-2227.2000.tb00417.x"},{"key":"2021120905521116300_R5","doi-asserted-by":"crossref","unstructured":"Omar SA, Salhadar A, Wooliever DE, Alsgaard PK. Late-onset neutropenia in very low birth weight infants. Pediatrics.\u20082000;106(4). Available at: www.pediatrics.org\/cgi\/content\/full\/106\/4\/e55","DOI":"10.1542\/peds.106.4.e55"},{"key":"2021120905521116300_R6","doi-asserted-by":"crossref","unstructured":"Krumbhaar EB. Leukemoid blood pictures in various clinical conditions. Am J Med Sci.\u20081926;172:519\u2013533","DOI":"10.1097\/00000441-192610000-00005"},{"key":"2021120905521116300_R7","doi-asserted-by":"crossref","unstructured":"Holland P, Maurer AM. Myeloid leukemoid reactions in children. Am J Dis Child.\u20081963;105:568\u2013575","DOI":"10.1001\/archpedi.1963.02080040570007"},{"key":"2021120905521116300_R8","doi-asserted-by":"crossref","unstructured":"Hill JM, Duncan CN. Leukemoid reactions. Am J Med Sci.\u20081941;201:847\u2013857","DOI":"10.1097\/00000441-194106000-00012"},{"key":"2021120905521116300_R9","unstructured":"Teng RJ, Chen BW, Ho MM. Transient leukemoid reaction in an extremely premature infant. Acta Pediatr Sin.\u20081994;35:225\u2013228"},{"key":"2021120905521116300_R10","doi-asserted-by":"crossref","unstructured":"Calhoun DA, Kirk JF, Christensen RD. Incidence, significance and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: a prospective evaluation. J Pediatr.\u20081996;129:403\u2013409","DOI":"10.1016\/S0022-3476(96)70073-2"},{"key":"2021120905521116300_R11","unstructured":"Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Revised reference changes for circulating neutrophils in very-low-birth weight neonates. Pediatrics.\u20081994;94:76\u201382"},{"key":"2021120905521116300_R12","doi-asserted-by":"crossref","unstructured":"Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophil cells. J Pediatr.\u20081979;95:89\u201398","DOI":"10.1016\/S0022-3476(79)80096-7"},{"key":"2021120905521116300_R13","doi-asserted-by":"crossref","unstructured":"Seibel NL, Sommer A, Miser J. Transient neonatal leukemoid reactions in mosaic trisomy 21. J Pediatr.\u20081984;104:251\u2013254","DOI":"10.1016\/S0022-3476(84)81006-9"},{"key":"2021120905521116300_R14","doi-asserted-by":"crossref","unstructured":"Brodeur GM, Dahl GV, Williams DL, Tipton RE, Kalwinsky DK. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood.\u20081980;55:691\u2013703","DOI":"10.1182\/blood.V55.4.691.bloodjournal554691"},{"key":"2021120905521116300_R15","doi-asserted-by":"crossref","unstructured":"Otero L, Conlon C, Reynolds P, Duval-Arnould B, Golden SM. Neonatal leukocytosis associated with prenatal administration of dexamethasone. Pediatrics.\u20081981;68:778\u2013780","DOI":"10.1542\/peds.68.6.778"},{"key":"2021120905521116300_R16","doi-asserted-by":"crossref","unstructured":"Barak M, Cohen A, Herschkowitz S. Total leukocyte and neutrophil changes associated with antenatal betamethasone administration in premature infants. Acta Paediatr.\u20081992;81:760\u2013763","DOI":"10.1111\/j.1651-2227.1992.tb12098.x"},{"key":"2021120905521116300_R17","doi-asserted-by":"crossref","unstructured":"Cohen A, Barak M, Herschkowitz S, Zecca S. Leukemoid reaction induced by prenatal administration of betamethasone. Acta Paediatr Jpn.\u20081993;35:534\u2013536","DOI":"10.1111\/j.1442-200X.1993.tb03104.x"},{"key":"2021120905521116300_R18","doi-asserted-by":"crossref","unstructured":"Nakamura T, Ezaki S, Takasaki J, Itabashi K, Ogawa Y. Leukemoid reaction and chronic lung disease in infants with very low birth weight. J Matern Fetal Neonatal Med.\u20082002;11:396\u2013399","DOI":"10.1080\/jmf.11.6.396.399"},{"key":"2021120905521116300_R19","doi-asserted-by":"crossref","unstructured":"Zanardo V, Magarotto M, Rosolen A. Neonatal leukemoid reaction and early development of bronchopulmonary dysplasia in a very low-birth-weight infant. Fetal Diagn Ther.\u20082001;16:150\u2013152","DOI":"10.1159\/000053900"},{"key":"2021120905521116300_R20","doi-asserted-by":"crossref","unstructured":"Zanardo V, Savio V, Giacomin C, Rinaldi A, Marzari F, Chiarelli S. Relationship between neonatal leukemoid reaction and bronchopulmonary dysplasia in low-birth-weight infants: a cross-sectional study. Am J Perinatol.\u20082002;19:379\u2013386","DOI":"10.1055\/s-2002-35612"},{"key":"2021120905521116300_R21","doi-asserted-by":"crossref","unstructured":"Rastogi S, Rastogi D, Sundaram R, Kulpa J, Parekh AJ. Leukemoid reaction in extremely low-birth-weight infants. Am J Perinatol.\u20081999;16:93\u201397","DOI":"10.1055\/s-2007-993843"},{"key":"2021120905521116300_R22","doi-asserted-by":"crossref","unstructured":"Ruldoph AJ, Smith CA. Idopathic respiratory distress syndrome of the newborn. J Pediatr.\u20081960;57:905\u2013921","DOI":"10.1016\/S0022-3476(60)80143-6"},{"key":"2021120905521116300_R23","doi-asserted-by":"crossref","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. Evaluation of subependymal and intraventricular hemorrhage. J Pediatr.\u20081978;92:529\u2013534","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2021120905521116300_R24","doi-asserted-by":"crossref","unstructured":"Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am.\u20081986;33:179\u2013201","DOI":"10.1016\/S0031-3955(16)34975-6"},{"key":"2021120905521116300_R25","doi-asserted-by":"crossref","unstructured":"Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics.\u20081988;82:527\u2013532","DOI":"10.1542\/peds.82.4.527"},{"key":"2021120905521116300_R26","doi-asserted-by":"crossref","unstructured":"Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Br J Ophthalmol.\u20081984;68:690\u2013697","DOI":"10.1136\/bjo.68.10.690"},{"key":"2021120905521116300_R27","doi-asserted-by":"crossref","unstructured":"McCarton CM, Wallace IF, Divon M, Vaughan HG Jr. Cognitive and neurologic development of the premature, small for gestational age infant through age 6: comparison of birth weight and gestational age. Pediatrics.\u20081996;98:1167\u20131178","DOI":"10.1542\/peds.98.6.1167"},{"key":"2021120905521116300_R28","doi-asserted-by":"crossref","unstructured":"Omar SA, Salhadar A, Wooliever DE, Alsgaard PK. Late-onset neutropenia in very low birth weight infants. Pediatrics.\u20082000;106(4). Available at: www.pediatrics.org\/cgi\/content\/full\/106\/4\/e55","DOI":"10.1542\/peds.106.4.e55"},{"key":"2021120905521116300_R29","unstructured":"Beno C, Pawar S, Wooliever DE, Alsagaard PK, Omar SA. Reference values for circulating absolute neutrophil count (ANC) in extremely low birth weight (ELBW) infants &lt;1000 g. Pediatr Res.\u20082001;49:A1846"},{"key":"2021120905521116300_R30","doi-asserted-by":"crossref","unstructured":"Jones CA, Cayabyab RG, Kwong KY, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res.\u20081996;39:966\u2013975","DOI":"10.1203\/00006450-199606000-00007"},{"key":"2021120905521116300_R31","unstructured":"Buron E, Garrote JA, Arranz E, Oyaguez P, Fernandez Calvo JL, Blanco Quiros A. Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome. Allergol Immunopathol (Madr).\u20081999;27:11\u201317"},{"key":"2021120905521116300_R32","doi-asserted-by":"crossref","unstructured":"Beresford MW, Shaw NJ. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res.\u20082002;52:973\u2013978","DOI":"10.1203\/00006450-200212000-00025"},{"key":"2021120905521116300_R33","doi-asserted-by":"crossref","unstructured":"Duggan PJ, Maalouf EF, Watts TL, et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet.\u20082001;358:1699\u20131700","DOI":"10.1016\/S0140-6736(01)06723-X"},{"key":"2021120905521116300_R34","doi-asserted-by":"crossref","unstructured":"Minagawa K, Tsuji Y, Ueda H, et al. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine.\u20082002;17:164\u2013170","DOI":"10.1006\/cyto.2001.0988"},{"key":"2021120905521116300_R35","doi-asserted-by":"crossref","unstructured":"Nelson KB, Grether JK, Dambrosia JM, et al. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res.\u20082003;53:600\u2013607","DOI":"10.1203\/01.PDR.0000056802.22454.AB"},{"key":"2021120905521116300_R36","doi-asserted-by":"crossref","unstructured":"Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics.\u20081999;103:766\u2013771","DOI":"10.1542\/peds.103.4.766"},{"key":"2021120905521116300_R37","doi-asserted-by":"crossref","unstructured":"Halpern MD, Holubec H, Dominguez JA, et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res.\u20082002;51:733\u2013739","DOI":"10.1203\/00006450-200206000-00012"},{"key":"2021120905521116300_R38","doi-asserted-by":"crossref","unstructured":"Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res.\u20081996;40:250\u2013256","DOI":"10.1203\/00006450-199608000-00010"},{"key":"2021120905521116300_R39","doi-asserted-by":"crossref","unstructured":"Ramsay PL, O'Brian Smith E, Hegemier S, Welty SE. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-selectin and ICAM-1. Pediatrics.\u20081998;102:927\u2013932","DOI":"10.1542\/peds.102.4.927"},{"key":"2021120905521116300_R40","doi-asserted-by":"crossref","unstructured":"Sallerfors B, Olofsson T. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays. Eur J Haematol.\u20081992;49:199\u2013207","DOI":"10.1111\/j.1600-0609.1992.tb00047.x"},{"key":"2021120905521116300_R41","doi-asserted-by":"crossref","unstructured":"Takahashi M, Kitagawa S, Masuyama JI, et al. Human monocyte-endothelial cell interaction induces synthesis of granulocyte-macrophage colony-stimulating factor. Circulation.\u20081996;93:1185\u20131193","DOI":"10.1161\/01.CIR.93.6.1185"},{"key":"2021120905521116300_R42","unstructured":"Lenhoff S, Rosberg B, Olofsson T. Granulocyte interactions with GM-CSF and G-CSF secretion by endothelial cells and monocytes. Eur Cytokine Netw.\u20081999;10:525\u2013532"},{"key":"2021120905521116300_R43","unstructured":"Takahashi GW, Andrews DF 3rd, Lilly MB, Singer JW, Alderson MR. Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood.\u20081993;81:357\u2013364"},{"key":"2021120905521116300_R44","unstructured":"Lenhoff S, Sallerfors B, Olofsson T. IL-10 as an autocrine regulator of CSF secretion by monocytes: disparate effects on GM-CSF and G-CSF secretion. Exp Hematol.\u20081998;26:299\u2013304"},{"key":"2021120905521116300_R45","unstructured":"Cannistra SA, Griffin J. Regulation of the production and function of granulocytes and monocytes. Semin Hematol.\u20081988;25:173\u2013188"},{"key":"2021120905521116300_R46","doi-asserted-by":"crossref","unstructured":"Gillan ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo MS. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood.\u20081994;84:1427\u20131433","DOI":"10.1182\/blood.V84.5.1427.1427"},{"key":"2021120905521116300_R47","doi-asserted-by":"crossref","unstructured":"Cairo M. Therapeutic implications of dysregulated colony-stimulating factor expression in neonates. Blood.\u20081993;82:2269\u20132272","DOI":"10.1182\/blood.V82.8.2269.bloodjournal8282269"},{"key":"2021120905521116300_R48","doi-asserted-by":"crossref","unstructured":"Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol.\u20082003;8:29\u201338","DOI":"10.1016\/S1084-2756(02)00190-2"},{"key":"2021120905521116300_R49","doi-asserted-by":"crossref","unstructured":"Arnon S, Grigg J, Silverman M. Pulmonary inflammatory cells in ventilated preterm infants: effects of surfactant treatment. Arch Dis Child.\u20081993;69:44\u201348","DOI":"10.1136\/adc.69.1_Spec_No.44"},{"key":"2021120905521116300_R50","doi-asserted-by":"crossref","unstructured":"Groneck P, Goetze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm infants. Pediatrics.\u20081994;93:712\u2013718","DOI":"10.1542\/peds.93.5.712"},{"key":"2021120905521116300_R51","unstructured":"Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase\/proteinase inhibitor imbalance. Am Rev Respir Dis.\u20081984;130:817\u2013821"},{"key":"2021120905521116300_R52","doi-asserted-by":"crossref","unstructured":"Kohelet D, Arbel E, Ballin A, Goldberg M. Variations in neutrophil count in preterm infants with respiratory distress syndrome who subsequently develop chronic lung disease. Am J Perinatol.\u20082000;3:159\u2013162","DOI":"10.1055\/s-2000-9279"},{"key":"2021120905521116300_R53","unstructured":"Anderson AB, Gennser G, Jeremy JY, Ohrlander S, Sayers L, Turnbull AC. Placental transfer and metabolism of betamethasone in human pregnancy. Obstet Gynecol.\u20081977;49:471\u2013474"},{"key":"2021120905521116300_R54","doi-asserted-by":"crossref","unstructured":"Ballard PL, Granberg P, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest.\u20081975;56:1548\u20131554","DOI":"10.1172\/JCI108236"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/1\/e43\/1033496\/zpe00705000e43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/1\/e43\/1033496\/zpe00705000e43.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:20:43Z","timestamp":1683105643000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/1\/e43\/72900\/Outcome-of-Extremely-Low-Birth-Weight-Infants-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,7,1]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-1379","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}